Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

The application of FAIMS gas analysis in medical diagnostics.

Covington JA, van der Schee MP, Edge AS, Boyle B, Savage RS, Arasaradnam RP.

Analyst. 2015 Jul 24. [Epub ahead of print]

PMID:
26205889
2.

Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results.

Arasaradnam RP, McFarlane M, Daulton E, Westenbrink E, O'Connell N, Wurie S, Nwokolo CU, Bardhan KD, Savage RS, Covington JA.

J Gastrointestin Liver Dis. 2015 Jun;24(2):197-201. doi: 10.15403/jgld.2014.1121.242.ury.

3.

Field cancerisation in colorectal cancer: a new frontier or pastures past?

Patel A, Tripathi G, Gopalakrishnan K, Williams N, Arasaradnam RP.

World J Gastroenterol. 2015 Apr 7;21(13):3763-72. doi: 10.3748/wjg.v21.i13.3763.

4.

The interplay of the gut microbiome, bile acids, and volatile organic compounds.

Sagar NM, Cree IA, Covington JA, Arasaradnam RP.

Gastroenterol Res Pract. 2015;2015:398585. doi: 10.1155/2015/398585. Epub 2015 Mar 3. Review.

5.

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?

Dhaliwal A, Zeino Z, Tomkins C, Cheung M, Nwokolo C, Smith S, Harmston C, Arasaradnam RP.

Frontline Gastroenterol. 2015 Jan;6(1):14-19. Epub 2014 Mar 17.

6.

Development and application of a new electronic nose instrument for the detection of colorectal cancer.

Westenbrink E, Arasaradnam RP, O'Connell N, Bailey C, Nwokolo C, Bardhan KD, Covington JA.

Biosens Bioelectron. 2015 May 15;67:733-8. doi: 10.1016/j.bios.2014.10.044. Epub 2014 Oct 23.

PMID:
25465796
7.

Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study.

Arasaradnam RP, Westenbrink E, McFarlane MJ, Harbord R, Chambers S, O'Connell N, Bailey C, Nwokolo CU, Bardhan KD, Savage R, Covington JA.

PLoS One. 2014 Oct 16;9(10):e107312. doi: 10.1371/journal.pone.0107312. eCollection 2014.

8.

Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.

Arasaradnam RP, McFarlane MJ, Ryan-Fisher C, Westenbrink E, Hodges P, Thomas MG, Chambers S, O'Connell N, Bailey C, Harmston C, Nwokolo CU, Bardhan KD, Covington JA.

PLoS One. 2014 Sep 30;9(9):e108750. doi: 10.1371/journal.pone.0108750. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118975. Hodges, Paula [corrected to Hodges, Phoebe].

9.

Clonal expansion of early to mid-life mitochondrial DNA point mutations drives mitochondrial dysfunction during human ageing.

Greaves LC, Nooteboom M, Elson JL, Tuppen HA, Taylor GA, Commane DM, Arasaradnam RP, Khrapko K, Taylor RW, Kirkwood TB, Mathers JC, Turnbull DM.

PLoS Genet. 2014 Sep 18;10(9):e1004620. doi: 10.1371/journal.pgen.1004620. eCollection 2014 Sep.

10.

Editorial: Metabolomic analysis of breath volatile organic compounds--a new scent for inflammatory bowel disease.

Arasaradnam RP, Covington J, Nwokolo CU.

Aliment Pharmacol Ther. 2014 Sep;40(6):732-3. doi: 10.1111/apt.12901. No abstract available.

PMID:
25123389
11.

Review article: next generation diagnostic modalities in gastroenterology--gas phase volatile compound biomarker detection.

Arasaradnam RP, Covington JA, Harmston C, Nwokolo CU.

Aliment Pharmacol Ther. 2014 Apr;39(8):780-9. doi: 10.1111/apt.12657. Epub 2014 Feb 20. Review.

PMID:
24612215
12.

Nasogastric feeding tubes - algorithm for correct placement.

Das I, Lin D, Muthalagappan S, Colby J, Trautner E, Wyre N, Wellings R, Nwokolo CU, Arasaradnam RP.

Clin Med. 2013 Oct;13(5):527-8. doi: 10.7861/clinmedicine.13-5-527. No abstract available.

PMID:
24115724
13.

Application of a novel tool for diagnosing bile acid diarrhoea.

Covington JA, Westenbrink EW, Ouaret N, Harbord R, Bailey C, O'Connell N, Cullis J, Williams N, Nwokolo CU, Bardhan KD, Arasaradnam RP.

Sensors (Basel). 2013 Sep 6;13(9):11899-912. doi: 10.3390/s130911899.

14.

A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease.

Arasaradnam RP, Ouaret N, Thomas MG, Quraishi N, Heatherington E, Nwokolo CU, Bardhan KD, Covington JA.

Inflamm Bowel Dis. 2013 Apr;19(5):999-1003. doi: 10.1097/MIB.0b013e3182802b26.

PMID:
23478806
15.

The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study.

Covington JA, Wedlake L, Andreyev J, Ouaret N, Thomas MG, Nwokolo CU, Bardhan KD, Arasaradnam RP.

Sensors (Basel). 2012 Sep 26;12(10):13002-18. doi: 10.3390/s121013002.

16.

18F-Fluorodeoxyglucose: the Trojan horse of PET/CT.

Arasaradnam RP, Penny R, Cullis J, Williams N, Wilson A, Bardhan KD.

Nucl Med Commun. 2012 Dec;33(12):1312. doi: 10.1097/MNM.0b013e328359d3a6. No abstract available.

PMID:
23014244
17.

Selective measurement of anti-tTG antibodies in coeliac disease and IgA deficiency: an alternative pathway.

Harrison E, Li KK, Petchey M, Nwokolo C, Loft D, Arasaradnam RP.

Postgrad Med J. 2013 Jan;89(1047):4-7. doi: 10.1136/postgradmedj-2011-130188. Epub 2012 Aug 7.

PMID:
22872871
18.

Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'.

Arasaradnam RP, Ouaret N, Thomas MG, Gold P, Quraishi MN, Nwokolo CU, Bardhan KD, Covington JA.

J Med Eng Technol. 2012 Oct;36(7):333-7. doi: 10.3109/03091902.2012.690015. Epub 2012 Jul 5.

PMID:
22764881
19.

Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.

Sung EZ, Arasaradnam RP, Jarvie EM, James S, Goodyear SJ, Borman RA, Snead D, Sanger GJ, Nwokolo CU.

Mol Biol Rep. 2012 Dec;39(12):9989-94. doi: 10.1007/s11033-012-1866-7. Epub 2012 Jun 29.

PMID:
22744429
20.

MYOD-1 in normal colonic mucosa--role as a putative biomarker?

Arasaradnam RP, Quraishi MN, Commane D, Mathers JC, Bradburn M.

BMC Res Notes. 2012 Jul 11;5:240. doi: 10.1186/1756-0500-5-240.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk